$0.940000
-0.02-2.10%
Last update: 9:06 AM
15 minutes delayed
Sangamo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sangamo Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.18 | $-0.15 | -20.0 % |
Mar 2024 | 2024-05-09 | $-0.27 | $-0.21 | -28.6 % |
Dec 2023 | 2024-03-13 | $-0.34 | $-0.26 | -30.8 % |
Sep 2023 | 2023-11-01 | $-0.59 | $-0.32 | -84.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $356.00K | $8.26M | -95.7 % |
Mar 2024 | 2024-05-09 | $481.00K | $6.65M | -92.8 % |
Dec 2023 | 2024-03-13 | $2.04M | $8.10M | -74.8 % |
Sep 2023 | 2023-11-01 | $9.40M | $10.40M | -9.63 % |
Sangamo Therapeutics (SGMO) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.18, which missed the estimate of $-0.15.
The Actual Revenue was $356K, which missed the estimate of $8.3M.
Browse earnings estimates, EPS, and revenue on all stocks.